Overview

KGI Life Science Advisors is a US-based boutique consulting and transaction advisory practice focused on cross-border strategic life science transactions between the US/Europe and Japan/Asia Pacific. However, our experience and reach are global covering more than 40 countries in all geographic regions. On average our principals have over 25 years of business development, licensing, financing and transaction experience.

​

Deal Connections

We are deal  connectors  with an ever-growing network of over 3,000 C-level contacts and decision-makers in more than 2,000 life science organizations worldwide spanning all industry sectors and therapeutic areas. 

​

Deal Execution

We are deal closers with a deal sheet that includes 35 transactions valued at more than $1.9 billion, not including transactions currently under negotiation.  While our sweet spot is emerging and small/mid-cap companies, we also work with large biopharma companies and leading service providers.

 

Preferred Provider Network

We understand that the business of life science is closely intertwined with R&D, clinical, regulatory, IP, manufacturing and other functions critical to success.  Unfortunately, we cannot do them all.  Therefore, we have an established network of preferred provider relationships with partners who can offer services in these areas to our clients. We have selected preferred providers based on our own positive experience of working with them as former clients.